Literature DB >> 9092627

Characterization of nuclear proteins that bind to the regulatory TGATTGGC motif in the human immunodeficiency virus type 1 long terminal repeat.

C Schwartz1, F Canonne-Hergaux, D Aunis, E Schaeffer.   

Abstract

We have recently elucidated the nature and function of transcription factors present in Jurkat, glial and neuronal cells that interact with modulatory region B, the nuclear receptor responsive element, in the long terminal repeat of human immunodeficiency virus type 1 (HIV-1). Considering the key role that the combination of host cell proteins plays in HIV-1 gene transcription, it appears essential to characterize proteins interacting with the adjacent region A. In vitro experiments revealed that the 5'-TGATTGGC-3'motif of region A is the target for at least three distinct proteins, one belonging to the nuclear factor I family, while two others are related to the cAMP response element binding (CREB) protein family. One of these proteins, present in DNA-protein complex C2, is formed by distinct polypeptides of relative molecular mass 43 000 and 50 000. We have purified the 43 kDa protein, which is distinct from CREB-43, and have shown that renatured p43 is able to specifically interact with site A. Transient expression experiments with vectors containing wild-type or mutant motif A revealed that basal HIV-1 gene transcription in Jurkat cells is regulated by antagonistic effects of the site A binding proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092627      PMCID: PMC146561          DOI: 10.1093/nar/25.6.1177

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

Review 1.  The human immunodeficiency virus type-1 long terminal repeat and its role in gene expression.

Authors:  J A Garcia; R B Gaynor
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1994

Review 2.  Signal transduction and gene regulation: the nuclear response to cAMP.

Authors:  E Lalli; P Sassone-Corsi
Journal:  J Biol Chem       Date:  1994-07-01       Impact factor: 5.157

3.  Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells.

Authors:  F Canonne-Hergaux; D Aunis; E Schaeffer
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.

Authors:  J P Taylor; R J Pomerantz; G V Raj; F Kashanchi; J N Brady; S Amini; K Khalili
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

5.  Constitutive NF-kappa B activity in neurons.

Authors:  C Kaltschmidt; B Kaltschmidt; H Neumann; H Wekerle; P A Baeuerle
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

6.  A synthetic retinoid antagonist inhibits the human immunodeficiency virus type 1 promoter.

Authors:  M O Lee; P D Hobbs; X K Zhang; M I Dawson; M Pfahl
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

7.  Involvement of transcription factor YB-1 in human T-cell lymphotropic virus type I basal gene expression.

Authors:  F Kashanchi; J F Duvall; J Dittmer; A Mireskandari; R L Reid; S D Gitlin; J N Brady
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

8.  Regulation of human immunodeficiency virus type 1 gene transcription by nuclear receptors in human brain cells.

Authors:  B E Sawaya; O Rohr; D Aunis; E Schaeffer
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

9.  Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.

Authors:  N J Deacon; A Tsykin; A Solomon; K Smith; M Ludford-Menting; D J Hooker; D A McPhee; A L Greenway; A Ellett; C Chatfield; V A Lawson; S Crowe; A Maerz; S Sonza; J Learmont; J S Sullivan; A Cunningham; D Dwyer; D Dowton; J Mills
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

10.  NF-kappa B activates the HIV promoter in neurons.

Authors:  A Rattner; M Korner; M D Walker; Y Citri
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

View more
  5 in total

Review 1.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.

Authors:  L A Pereira; K Bentley; A Peeters; M J Churchill; N J Deacon
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  HIV-1 gp120 Impairs Spatial Memory Through Cyclic AMP Response Element-Binding Protein.

Authors:  Jenny Shrestha; Maryline Santerre; Charles N S Allen; Sterling P Arjona; Carmen Merali; Ruma Mukerjee; Kumaraswamy Naidu Chitrala; Jin Park; Asen Bagashev; Viet Bui; Eliseo A Eugenin; Salim Merali; Marcus Kaul; Jeannie Chin; Bassel E Sawaya
Journal:  Front Aging Neurosci       Date:  2022-05-09       Impact factor: 5.702

3.  HIV-1 induced nuclear factor I-B (NF-IB) expression negatively regulates HIV-1 replication through interaction with the long terminal repeat region.

Authors:  Sai Vikram Vemula; Ravichandran Veerasamy; Viswanath Ragupathy; Santanu Biswas; Krishnakumar Devadas; Indira Hewlett
Journal:  Viruses       Date:  2015-02-05       Impact factor: 5.048

4.  Identification of novel genes associated with HIV-1 latency by analysis of histone modifications.

Authors:  Kyung-Chang Kim; Sunyoung Lee; Junseock Son; Younghyun Shin; Cheol-Hee Yoon; Chun Kang; Byeong-Sun Choi
Journal:  Hum Genomics       Date:  2017-05-12       Impact factor: 4.639

5.  Distinctive variation in the U3R region of the 5' Long Terminal Repeat from diverse HIV-1 strains.

Authors:  Christelle Mbondji-Wonje; Ming Dong; Xue Wang; Jiangqin Zhao; Viswanath Ragupathy; Ana M Sanchez; Thomas N Denny; Indira Hewlett
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.